Latest Alivus Life Sciences stock price
Alivus Life Sciences P/E Ratio
ALIVUS • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
22.88
Moderate Valuation
High - Growth expectations or overvalued
Current Valuation Metrics
P/E Ratio
22.88
Current Price
₹906.85
EPS (TTM)
₹39.63
Exchange
NSE
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
46.26
Sector Median
49.99
Sector Rank
#3 of 11
Sector Percentile
27.3%
Key P/E Ratio Insights for Alivus Life Sciences
- Trading at discount to sector average PE of 46.26
View the ALIVUS equity price for detailed stock performance.
Related Pages for Alivus Life Sciences
Additional stock information and data for ALIVUS
Sector P/E Ratio Comparison
Comparing Alivus Life Sciences with other companies in Healthcare sector
Sector Average
46.26
Sector Median
49.99
Lowest P/E
10.8
Highest P/E
72.08
Companies
11
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Natco Pharma | NATCOPHARM | 10.8 | ₹17,006 | Low |
| SMS Lifesciences | SMSLIFE | 22.27 | ₹354 | Moderate |
| Dishman Carbogen Amcis | DCAL | 29.48 | ₹4,131 | High |
| Procter & Gamble Health | PGHL | 31.12 | ₹9,529 | High |
| Supriya Lifescience | SUPRIYA | 33.11 | ₹6,053 | High |
| Poly Medicure | POLYMED | 49.99 | ₹18,253 | High |
| Medicamen Biotech | MEDICAMEQ | 57.88 | ₹538 | High |
| Cohance Lifesciences | COHANCE | 62.63 | ₹19,216 | High |
| Biocon | BIOCON | 67.55 | ₹51,493 | High |
| Sai Life Sciences | SAILIFE | 71.91 | ₹20,532 | High |